

[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI

[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
Terence Flynn Maintained (CCCC) at Hold with Increased Target to $8 on, Feb 26th, 2024
Terence Flynn of Morgan Stanley, Maintained "C4 Therapeutics, Inc." (CCCC) at Hold with Increased Target from $1 to $8 on, Feb 26th, 2024.
Terence has made no other calls on CCCC in the last 4 months.
There are 4 other peers that have a rating on CCCC. Out of the 4 peers that are also analyzing CCCC, 1 agrees with Terence's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eric Joseph of "JP Morgan" Upgraded from Sell to Hold and Held Target at $6 on, Monday, January 29th, 2024
These are the ratings of the 3 analyists that currently disagree with Terence
- Bradley Canino of "Stifel" Reiterated at Strong Buy with Increased Target to $13 on, Friday, February 23rd, 2024
- Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $16 on, Friday, November 3rd, 2023
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Thursday, November 2nd, 2023
Contributing Sources